Atlas Trials

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Clinical trial NCT00057980 · COMPLETED

Trial details

NCT number
NCT00057980
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2002-10-01
Primary completion
2007-02-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.